Literature DB >> 30517634

Can MoCA and MMSE Be Interchangeable Cognitive Screening Tools? A Systematic Review.

Glória S A Siqueira1, Paula de M S Hagemann1, Daniela de S Coelho2, Flávia Heloísa Dos Santos1,2,3,4, Paulo H F Bertolucci2.   

Abstract

BACKGROUND AND OBJECTIVES: Cognitive disorders may be an early sign of neuropsychiatric disorders; however, it remains unclear whether the screening measures are interchangeable. The aim of this study was to contrast the most commonly used screening tools-Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)-for early detection of neurocognitive disorder (NCD). RESEARCH DESIGN AND METHODS: This study presents a descriptive systematic review and informative literature according to the Cochrane Foundation's guidelines. The keywords "Mini-Mental State Examination" and "Montreal Cognitive Assessment" were searched in the Web of Science, SciELO, and LILACS databases.
RESULTS: Fifty-one studies were selected including a total sample of 11,870 participants (8,360 clinical patients and 3,510 healthy controls). Most studies were published in the past 5 years using a cross-sectional design, carried out across the world. They were organized by age ranges (18-69 years and 20-89 years), years of schooling, and mental status (with and without mental and behavior disorders). Sixteen of 18 studies had participants aged 18-69 years, and 21 out of 33 studies within the older set suggested that the MoCA is a more sensitive tool for detecting NCD. DISCUSSION AND IMPLICATIONS: Thirty-seven studies suggested that the MoCA is a more sensitive tool for NCD detection because it assesses executive function and visuospatial abilities. Some individuals who demonstrated normal cognitive function on the MMSE had lower performance on the MoCA. However, it seems necessary to establish different cutoffs based on years of schooling to avoid false positives. Future studies should contrast MoCA with other screening tools designed for NCD assessment.
© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cognition; Mini-Mental State Examination; Montreal Cognitive Assessment; Psychology of aging/psychiatry

Mesh:

Year:  2019        PMID: 30517634     DOI: 10.1093/geront/gny126

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  16 in total

1.  The montreal cognitive assessment and mini-mental state examination visuoexecutive subtests in acute ischemic stroke patients and their correlations with demographic and clinical factors.

Authors:  Wei Wang; Fang-Ming Dong; Kai Shao; Shang-Zun Guo; Zhong-Min Zhao; Yi-Ming Yang; Ya-Xue Song; Jian-Hua Wang
Journal:  Acta Neurol Belg       Date:  2020-11-21       Impact factor: 2.396

2.  Effect of Process-Based Multi-Task Cognitive Training Program on Executive Function in Older Adults With Mild Cognitive Impairment: Study Rationale and Protocol Design for a Randomized Controlled Trial.

Authors:  Xia Zhao; Lina Wang; Chenxi Ge; Xiaoshen Liu; Mei Chen; Chen Zhang
Journal:  Front Psychiatry       Date:  2020-07-23       Impact factor: 4.157

Review 3.  Diagnostic Criteria of Postoperative Cognitive Dysfunction: A Focused Systematic Review.

Authors:  Kim van Sinderen; Lothar A Schwarte; Patrick Schober
Journal:  Anesthesiol Res Pract       Date:  2020-11-16

4.  The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis.

Authors:  Buhai Wang; Shiwei Fu; Yuxiang Huang; Liqin Liu; Yichen Liang; Wenxian An; Yaqin Fan; Yisa Zhao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

5.  The Frontal Assessment Battery (FAB) and its sub-scales: validation and updated normative data in an Italian population sample.

Authors:  Edoardo Nicolò Aiello; Antonella Esposito; Chiara Gramegna; Valentina Gazzaniga; Stefano Zago; Teresa Difonzo; Ildebrando Marco Appollonio; Nadia Bolognini
Journal:  Neurol Sci       Date:  2021-06-29       Impact factor: 3.830

6.  Determining Appropriate Screening Tools and Cutoffs for Cognitive Impairment in the Chinese Elderly.

Authors:  Shaowei Zhang; Qi Qiu; Shixing Qian; Xiang Lin; Feng Yan; Lin Sun; Shifu Xiao; Jinghua Wang; Yuan Fang; Xia Li
Journal:  Front Psychiatry       Date:  2021-12-02       Impact factor: 4.157

Review 7.  Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.

Authors:  Marion Pépin; Ana Carina Ferreira; Mustafa Arici; Maie Bachman; Michelangela Barbieri; Inga Arune Bumblyte; Sol Carriazo; Pilar Delgado; Liliana Garneata; Konstantinos Giannakou; Olivier Godefroy; Tomasz Grodzicki; Aleksandra Klimkowicz-Mrowiec; Justina Kurganaite; Sophie Liabeuf; Carmen Antonia Mocanu; Giuseppe Paolisso; Goce Spasovski; Evgueniy Stefanov Vazelov; Davide Viggiano; Carmine Zoccali; Ziad A Massy; Andrzej Więcek
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

8.  Investigation Regarding Early Cognitive Function of Women in the Postpartum Period and the Analysis of Influencing Factors.

Authors:  Ting Qiu; Hui Wen; Zhen-Xing Liu; Xiao-Ping Pan; Tao Zeng
Journal:  Risk Manag Healthc Policy       Date:  2021-09-10

9.  Functional correlates of self-reported energy levels in the Health, Aging and Body Composition Study.

Authors:  Rebecca Ehrenkranz; Andrea L Rosso; Briana N Sprague; Qu Tian; Theresa Gmelin; Nicolaas Bohnen; Eleanor M Simonsick; Nancy W Glynn; Caterina Rosano
Journal:  Aging Clin Exp Res       Date:  2021-03-10       Impact factor: 3.636

10.  Anatomical Brain Changes and Cognitive Abilities in Patients with Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease.

Authors:  Branka Filipovic; Vesna Đuric; Natasa Filipovic; Stanimir Kiurski; Jamal Al Kiswani; Branka Markovic; Darko Laketic; Marija Marjanovic-Haljilji; Slobodan Kapor; Branislav R Filipovic
Journal:  Can J Gastroenterol Hepatol       Date:  2021-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.